본문 바로가기
KERD
논문KCI 등재

약물 중단에도 지속되는 약인성 파킨슨증후군 환자의 한의 치험 1례

A Case Report of Persistent Drug-Induced Parkinsonism After Drug Discontinuation

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류한의학

초록

This study examined the effectiveness of Korean medical treatment in a patient with persistent drug-induced parkinsonism after drug discontinuation. The changes in symptoms were assessed using the unified parkinson's disease rating scale (UPDRS), postural instability-gait disturbance (PIGD) score, and the 20 m gait time and steps. After 22 days of hospitalization, the UPDRS, PIGD score, and 20 m gait time and steps showed clinically significant improvement. The improvement persisted after discharge. This study indicated that Korean medical treatment could be an effective alternative therapy for treating persistent drug-induced parkinsonism after drug discontinuation.

Abstract

This study examined the effectiveness of Korean medical treatment in a patient with persistent drug-induced parkinsonism after drug discontinuation. The changes in symptoms were assessed using the unified parkinson's disease rating scale (UPDRS), postural instability-gait disturbance (PIGD) score, and the 20 m gait time and steps. After 22 days of hospitalization, the UPDRS, PIGD score, and 20 m gait time and steps showed clinically significant improvement. The improvement persisted after discharge. This study indicated that Korean medical treatment could be an effective alternative therapy for treating persistent drug-induced parkinsonism after drug discontinuation.

참고문헌 (29)

  1. Miller LG, "Neurologic approach to drug-induced movement disorders: a study of 125 patients", South Med J, 83(5), pp.525~532 (1990)
  2. Hassin-Baer S, "Clinical characteristics of neuroleptic-induced parkinsonism", J Neural Transm, 108(11), pp.1299~1308 (2001)
  3. Barbosa MT, "Parkinsonism and Parkinson’s disease in the elderly: a community-based survey in Brazil", Mov Disord, 21(6), pp.800~808 (2006)
  4. Poewe W, "Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice", Mov Disord, 18(Suppl 7), pp.S16~S21 (2003)
  5. FP- CIT single photon emission computed tomography findings in drug-induced parkinsonism, "Schizophr Res", 2012, 40~45
  6. Lee PH, "Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism", J Neurol Neurosurg Psychiatry, 78(11), pp.1250~1252 (2007)
  7. Bower JH, "Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990", Neurology, 52(6), pp.1214~1220 (1999)
  8. 정성국, "사상처방을 활용한 약물 유발성 속발성 파킨슨증 치험 2례", 사상체질의학회지, 24(4), pp.109~119 (2012), 사상체질의학회[DOI]
  9. Kim H, "Clinical study on a case of a patient with a glossal tremor caused by a side effect of drugs", J Orient Neuropsychiatry, 14(1), pp.133~139 (2003)
  10. 김은지, "조등산(Diaoteng-san, Choto-san, 釣藤散)과 GB34(陽陵泉) 전침치료를 활용한 약인성파킨슨증후군 환자의 증례 1례", 대한한방내과학회지, 38(5), pp.600~609 (2017), 대한한방내과학회
  11. 김연진, "약인성 파킨슨증후군 환자의 한방 치험 1례", 대한한방내과학회지, 37(2), pp.381~388 (2016), 대한한방내과학회
  12. 이상화, "약인성 급성 이상운동증 환자의 한방 치험 1례", 대한한방내과학회지, 38(5), pp.853~861 (2017), 대한한방내과학회
  13. 박성욱, "약침의 정석 : 통증편", pp.44~ (2020), 우리의학서적
  14. Ramaker C, "Systematic evaluation of rating scales for impairment and disability in Parkinson's disease", Movement Disorders, 17(5), pp.867~876 (2002)
  15. Jankovic JM, "Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort", Neurology, 40(10), pp.1529~1534 (1990)
  16. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (2013), American Psychiatric Association
  17. Jiméez-Jiméez FJ, "Drug-induced parkinsonism in a movement disorders unit: a four-year survey", Parkinsonism Relat Disord, 2(3), pp.145~149 (1996)
  18. Kenney C, "Metoclopramide, an increasingly recognized cause of tardive dyskinesia", J Clin Pharmacol, 48(3), pp.379~384 (2008)
  19. Blanchet P, "Drug-induced parkinsonism:diagnosis and management", Journal of parkinsonism and restless legs syndrome, 2016, pp.83~91 (2016)
  20. Sethi KD, "Movement disorders induced by dopamine blocking agents", Semin Neurol, 21(1), pp.59~68 (2001)
  21. Tolosa E, "DAT imaging in drug-induced and psychogenic parkinsonism", Mov Disord, 18(Suppl 7), pp.28~33 (2003)
  22. DA van de Vijver, "Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users", Acta Neurol Scand, 105(1), pp.8~12 (2002)
  23. Lisa MS, "The clinically important difference on the unified Parkinson's disease rating scale", Arch Neurol, 67(1), pp.64~70 (2010)
  24. Baek H, "Comparison of Administration Routes on the Protective Effects of Bee Venom Phospholipase A2 in a Mouse Model of Parkinson's Disease", Frontiers in Aging Neuroscience, 10, pp.179~ (2018)
  25. Cho SY, "Efficacy of Combined Treatment with Acupuncture and Bee Venom Acupuncture as an Adjunctive Treatment for Parkinson's Disease", J Altern Complement, 24(1), pp.25~32 (2018)
  26. 김하리, "몸통굽힘증을 주소로 하는 파킨슨병 환자의 자세 이상에 대한 한의 치료 증례 1례", 대한한방내과학회지, 40(2), pp.220~227 (2019), 대한한방내과학회[DOI]
  27. 박유경, "소양인 파킨슨병 환자의 한양방 병행치료 장기 경과관찰 보고 3례", 사상체질의학회지, 28(4), pp.361~371 (2016), 사상체질의학회[DOI]
  28. 박유경, "우울증을 동반한 少陽人 파킨슨병 환자 치험 1례", 사상체질의학회지, 27(3), pp.356~365 (2015), 사상체질의학회[DOI]
  29. Kim SN, "Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson’s disease", PLoS One, 6(11), pp.e27566~ (2011)

관련 논문AI추천

이 간행물의 다른 논문 (15건)